Brexit contingency plans revealed
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Contingency plans set out by the UK government outlining how medicines and medical devices would be regulated and tested in the event of a ‘no deal’ exit by Britain from the European Union (EU) at the end of March 2019 have been welcomed by the Proprietary Association of Great Britain (PAGB).